The best indicator for Nasdaq, Inc. (NDAQ)
We backtested 366 indicators across daily, weekly and hourly charts on real Nasdaq, Inc. (NDAQ) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
TRIMA 200 Trend
On the daily chart, this is the strongest risk-adjusted edge we found for Nasdaq, Inc. (NDAQ) over ~23.9 years — beating buy-and-hold by 0.4% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Nasdaq, Inc. (NDAQ) — trailing buy-and-hold by 2.1% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | TRIMA 200 Trend ✓ | Daily | 14.2% | 0.73 | -41.5% | 35.3% | 51 | 0.4% |
| 2 | MA Ribbon ✓ | Weekly | 12.9% | 0.68 | -34.3% | 57.1% | 21 | -0.8% |
| 3 | TRIMA 30 Trend ✓ | Weekly | 13.7% | 0.67 | -45.2% | 54.3% | 35 | -0.0% |
| 4 | FRAMA 10/30 Cross ✓ | Weekly | 13.9% | 0.65 | -53.7% | 55.9% | 93 | 0.2% |
| 5 | T3 100 Trend ✓ | Daily | 11.8% | 0.64 | -54.1% | 41.7% | 60 | -2.0% |
| 6 | SMA 10/40 Cross ✓ | Weekly | 13.9% | 0.64 | -55.8% | 70.6% | 17 | 0.2% |
| 7 | SMA 50/200 Cross ✓ | Daily | 13.5% | 0.63 | -69.3% | 68.8% | 16 | -0.2% |
| 8 | Zero-Lag EMA Cross ✓ | Weekly | 13.7% | 0.63 | -50.3% | 59.6% | 52 | -0.0% |
| 9 | ZLEMA 10/30 Cross ✓ | Weekly | 13.7% | 0.63 | -50.3% | 59.6% | 52 | -0.0% |
| 10 | CCI (30) ✓ | Weekly | 13.7% | 0.63 | -54.9% | 45.7% | 35 | 0.0% |
| 11 | Relative Volatility Index ✓ | Weekly | 13.2% | 0.62 | -61.9% | 48.6% | 70 | -0.5% |
| 12 | Balance of Power ✓ | Weekly | 13.3% | 0.61 | -49.7% | 51.6% | 64 | -0.4% |
| 13 | EMA 8/21 Cross ✓ | Weekly | 12.8% | 0.6 | -51.6% | 52.2% | 23 | -0.9% |
| 14 | DEMA 20/50 Cross ✓ | Weekly | 11.9% | 0.6 | -35.8% | 55.0% | 20 | -1.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Nasdaq, Inc. (NDAQ), TRIMA 200 Trend on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.